Median Local Anaesthetic dose (MLAD) of Intrathecal Prilocaïne in total hip arthroplasty with the anterior approach.

Reinier de Graaf Groep0 个研究点开始时间: 2016年7月25日最近更新: 2016年8月22日

适应症

试验速览

暂无简介。

•In order to be eligible to participate in this study, a subject must meet all of the following criteria:
•- ASA I to III
•- 18y or older
•- Primary uncemented THA with anterior approach
•- Willing to participate
•- Speaking Dutch language
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 10
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 15

•A potential subject who meets any of the following criteria will be excluded from participation in this study:
•- Hypersensitivity to local anesthetics or any of the other excipients of prilocaine
•- Any other contraindications relate to intrathecal anesthesia
•- CNS disease, e.g. meningitis, tumor, poliomyelitis, cerebral hemorrhage
•- Spinal stenosis and diseases or recent trauma to the cervical column
•- Pernicious anemia with symptoms related to cervical degradation
•- Pyogenic infections of the skin close to the injection site
•- Cardiogenic or hypovolemic shock
•- Disturbance in coagulation or treatment with anti-coagulants
•- Patient is participating in a medicinal study
•- Noncompliant to intrathecal anesthesia
•- Patients who are incompetent to decide

发起方

Reinier de Graaf Groep